Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation.
about
Internal ribosome entry site-based vectors for combined gene therapyGalectin-2 induces a proinflammatory, anti-arteriogenic phenotype in monocytes and macrophagesS100A1: A novel and essential molecular component for postischemic angiogenesisMRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2.Glutaredoxin-1 overexpression enhances neovascularization and diminishes ventricular remodeling in chronic myocardial infarction.Early vessel destabilization mediated by Angiopoietin-2 and subsequent vessel maturation via Angiopoietin-1 induce functional neovasculature after ischemia.Pleiotrophin gene therapy for peripheral ischemia: evaluation of full-length and truncated gene variantsArteriogenic therapy based on simultaneous delivery of VEGF-A and FGF4 genes improves the recovery from acute limb ischemiaCardiac shockwave therapy improves myocardial function in patients with refractory coronary artery disease by promoting VEGF and IL-8 secretion to mediate the proliferation of endothelial progenitor cells.Long-term safety and stability of angiogenesis induced by balanced single-vector co-expression of PDGF-BB and VEGF164 in skeletal muscle.Negative pressure wound therapy promotes vessel destabilization and maturation at various stages of wound healing and thus influences wound prognosis.Suppression of oxidative stress in endothelial progenitor cells promotes angiogenesis and improves cardiac function following myocardial infarction in diabetic mice.Exercise training and peripheral arterial disease.Tongxinluo Improves Cardiac Function and Ameliorates Ventricular Remodeling in Mice Model of Myocardial Infarction through Enhancing Angiogenesis.FACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemia.Repetitive myocardial ischemia promotes coronary growth in the adult mammalian heart.Cell and gene therapy approaches for cardiac vascularization.Gene therapy for ischemic heart disease.Taming of the wild vessel: promoting vessel stabilization for safe therapeutic angiogenesis.Adjuvant early and late cardioprotective therapy: access to the heart.Advances in growth factor delivery for therapeutic angiogenesis.VEGF-B: a more balanced approach toward cardiac neovascularization?Optimizing the host substrate environment for cardiac angiogenesis, arteriogenesis, and myogenesis.Cardiac gene therapy with adeno-associated virus-based vectors.Thymosin β4 attenuates microcirculatory and hemodynamic destabilization in sepsis.Thymosin-β4-mediated therapeutic neovascularization: role of the PI3K/AKT pathway.Differential regulation of blood flow-induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling.The bottleneck stent model for chronic myocardial ischemia and heart failure in pigs.Selective Pressure-Regulated Retroinfusion for Gene Therapy Application in Ischemic Heart Disease.Vascular endothelial growth factor-B: Impact on physiology and pathology.SDF-1 fused to a fractalkine stalk and a GPI anchor enables functional neovascularization.
P2860
Q26866358-DB13A19E-1746-439A-9B53-D088B1B8121AQ27309121-5F2C0AF8-D343-466A-99D3-F2AF364C54EBQ28282541-A6F8424B-C373-4D30-B542-735A9258E61DQ30317274-3B86DC1A-0B03-4A03-B664-303988304898Q34241559-270CC780-C46F-4972-8564-274DF3696B68Q34685212-DD296627-F30E-4184-A150-D77044BBBAC9Q34695480-F95B9398-8B92-436B-B909-F57635197667Q34788546-2C951755-252D-42F9-A17F-D307DE029769Q35868953-9018B88D-0FCC-4A14-94BD-7A1A5299353FQ36587779-2D2B59EF-0C42-4299-83FE-320590191C48Q36742246-5D7E1CBE-DD6C-4EED-A6A1-B837161AA5D9Q36953381-85570FA7-1BAA-419A-8D22-CD8CCE4D6092Q37157213-9A78B4CA-223E-4F89-93ED-10CD464DC881Q37166684-CEF3B6B1-5A60-4335-9240-D576FD05D1ECQ37295222-F85A403E-483C-400F-B218-64B430F1E9B2Q37328790-162A1AF8-04EA-4018-A3D2-EE810CF22DC0Q37512327-F848D3ED-6919-47FA-A6DD-C8E80139C5D4Q37857290-B657B03B-905F-4AE5-BBD3-EA5D03BF7FBCQ37958947-4C74E3E8-01EB-4A66-966A-06ABA6BC9CDCQ37982681-C3A101BF-3586-49D3-9D02-87C3BB9DE421Q38060077-A34FD301-89D2-4B8B-A565-C5FA5BE3AB19Q38334257-E9712635-0AC2-45E2-A2F5-2FBB1F5365B6Q38748690-B126872F-DFAC-4E0F-BFB6-1F51D2AC595EQ39124456-BF445DA7-ECC3-47CA-A000-35CA13B76280Q41532527-F4777301-B6BD-46D0-BD66-6A62256FE19AQ42172475-F711053B-638D-4605-9E21-802004C45947Q42319216-329C09DB-7BF5-419F-85AD-F4AC68A35708Q44479695-9D3EDF20-EB28-42E0-9A60-76F4A7047173Q45862456-F8ADAA52-0D81-4B03-A1B3-33E13EB56D4BQ47450318-6A7D1D02-8869-446F-AFE9-54D973723B42Q50929234-54FABBAB-A8FF-4C6B-9AB0-BA5CBEEEAAA1
P2860
Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Cotransfection of vascular end ...... ion role of vessel maturation.
@en
Cotransfection of vascular end ...... ion role of vessel maturation.
@nl
type
label
Cotransfection of vascular end ...... ion role of vessel maturation.
@en
Cotransfection of vascular end ...... ion role of vessel maturation.
@nl
prefLabel
Cotransfection of vascular end ...... ion role of vessel maturation.
@en
Cotransfection of vascular end ...... ion role of vessel maturation.
@nl
P2093
P1476
Cotransfection of vascular end ...... ion role of vessel maturation.
@en
P2093
Achim Pfosser
Alexander Wuchrer
Andrea Fritz
Chiraz El-Aouni
Christian Kupatt
Corinna Lebherz
Eckart Thein
Franziska Globisch
Jan Horstkotte
Michael Thormann
P304
P356
10.1016/J.JACC.2010.03.050
P407
P577
2010-07-01T00:00:00Z